Bio Techne | TECH - Cash And Equivalent


Bio Techne reported $264.71M in Cash and Equivalent for its fiscal quarter ending in June of 2026.





Cash And Equivalent Change Date
Agilent USD 1.76B 49M Jun/2026
Becton, Dickinson and Co. USD 708M 105M Jun/2026
Bio Techne USD 264.71M 54.89M Jun/2026
Bio-Rad Laboratories USD 517M 9.8M Jun/2026
Bruker USD 184.9M 51.5M Jun/2026
Charles River Laboratories USD 192.02M 195K Jun/2026
Danaher USD 5.68B 1.33B Sep/2026
Illumina USD 1.09B 329M Mar/2026
IQVIA Holdings USD 2.25B 340M Sep/2026
Merck EUR 2.74B 415M Mar/2026
Mettler Toledo International USD 51.38M 9.19M Jun/2026
OraSure Technologies USD 160.58M 16.38M Jun/2026
Pacific Biosciences Of California USD 61M 4.73M Jun/2026
Repligen USD 726.96M 120.18M Sep/2026
Revvity USD 1.02B 162.62M Jun/2026
Standard Biotools USD 265.77M 147.56M Mar/2026
Thermo Fisher Scientific USD 5.46B 1.4B Sep/2026
Waters USD 539M 77M Jun/2026